148 related articles for article (PubMed ID: 34635483)
1. Implications of screening for coexisting transthyretin amyloidosis and aortic stenosis.
Cheng R; Griffin J
Heart; 2022 Jan; 108(1):11-13. PubMed ID: 34635483
[No Abstract] [Full Text] [Related]
2. Case With Transthyretin Amyloid Cardiomyopathy Complicated With Rapidly Progressive Aortic Stenosis Possibly Caused by Amyloid Deposition in the Aortic Valve.
Fujimoto T; Yamano T; Miyagawa-Hayashino A; Naiki H; Ueda M; Tasaki M; Yamano M; Zen K; Numata S; Matoba S
Circ Cardiovasc Imaging; 2021 Nov; 14(11):e013357. PubMed ID: 34727706
[No Abstract] [Full Text] [Related]
3. Association between aortic stenosis and hereditary transthyretin amyloidosis.
Ripoll-Vera T; Álvarez Rubio J; Iglesias M; Losada López I; Ferrer-Nadal A; González Moreno J
Rev Esp Cardiol (Engl Ed); 2021 Feb; 74(2):185-187. PubMed ID: 32778403
[No Abstract] [Full Text] [Related]
4. Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis.
Longhi S; Lorenzini M; Gagliardi C; Milandri A; Marzocchi A; Marrozzini C; Saia F; Ortolani P; Biagini E; Guidalotti PL; Leone O; Rapezzi C
JACC Cardiovasc Imaging; 2016 Mar; 9(3):325-7. PubMed ID: 26189123
[No Abstract] [Full Text] [Related]
5. Simultaneous onset of acute myocardial infarction, bicuspid aortic stenosis, and cardiac transthyretin amyloidosis-A clinically complex confluence.
Moscoso J; Rojas P; Baltodano R; Cachicatari A; Quiroz J; Velarde K; Levano G; Pimentel C
Echocardiography; 2024 Jan; 41(1):e15733. PubMed ID: 38284668
[TBL] [Abstract][Full Text] [Related]
6. [Cardiac amyloidosis and aortic stenosis: what do we know?].
Sena G; Ruotolo I; Zaccaro A; Ponziani A; Saturi G; Gagliardi C; Biagini E; Longhi S
G Ital Cardiol (Rome); 2024 Jul; 25(7):483-490. PubMed ID: 38916463
[TBL] [Abstract][Full Text] [Related]
7. Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis: Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement.
Treibel TA; Fontana M; Gilbertson JA; Castelletti S; White SK; Scully PR; Roberts N; Hutt DF; Rowczenio DM; Whelan CJ; Ashworth MA; Gillmore JD; Hawkins PN; Moon JC
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511979
[TBL] [Abstract][Full Text] [Related]
8. [Wild-type transthyretin-related cardiac amyloidosis and degenerative aortic stenosis: Two inter-related pathologies in the elderly].
Calero Núñez S; Tercero Martínez A; García López JC; Jiménez-Mazuecos J
Rev Esp Geriatr Gerontol; 2017; 52(3):167-170. PubMed ID: 27292540
[TBL] [Abstract][Full Text] [Related]
9. Transthyretin Cardiac Amyloidosis and Aortic Stenosis: Connection and Therapeutic Implications.
Penalver J; Ambrosino M; Jeon HD; Agrawal A; Kanjanahattakij N; Pitteloud M; Stempel J; Amanullah A
Curr Cardiol Rev; 2020; 16(3):221-230. PubMed ID: 31544701
[TBL] [Abstract][Full Text] [Related]
10. Transthyretin cardiac amyloid and aortic stenosis in the elderly, the role of nuclear imaging.
Merli E; Giudice ED; Antonopoulos A; Amadei G; Varani E
Int J Cardiovasc Imaging; 2017 Jun; 33(6):947-949. PubMed ID: 28155044
[No Abstract] [Full Text] [Related]
11. In the midst of a dangerous intersection with unclear therapeutic strategies: a challenging case of severe aortic stenosis.
Gallone G; Landra F; D'Ascenzo F; Conrotto F; Casoni R; Bruno F; Omedè P; Alunni G; Andreis A; Vairo A; Giorgi M; Fava A; De Ferrari GM
BMC Cardiovasc Disord; 2020 Jun; 20(1):261. PubMed ID: 32487051
[TBL] [Abstract][Full Text] [Related]
12. Value of Longitudinal Strain to Identify Wild-Type Transthyretin Amyloidosis in Patients With Aortic Stenosis.
Robin G; Cognet T; Bouisset F; Cariou E; Méjean S; Pradel S; Colombat M; Galinier M; Carrié D; Lairez O;
Circ J; 2021 Aug; 85(9):1494-1504. PubMed ID: 33980765
[TBL] [Abstract][Full Text] [Related]
13. Quantification of Myocardial Extracellular Volume With Planning Computed Tomography for Transcatheter Aortic Valve Replacement to Identify Occult Cardiac Amyloidosis in Patients With Severe Aortic Stenosis.
Oda S; Kidoh M; Takashio S; Inoue T; Nagayama Y; Nakaura T; Shiraishi S; Tabata N; Usuku H; Kaikita K; Tsujita K; Ikeda O
Circ Cardiovasc Imaging; 2020 May; 13(5):e010358. PubMed ID: 32370615
[No Abstract] [Full Text] [Related]
14. Tafamidis for the treatment of transthyretin amyloidosis.
Lorenzini M; Elliott PM
Future Cardiol; 2019 Mar; 15(2):53-61. PubMed ID: 30767672
[TBL] [Abstract][Full Text] [Related]
15. Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact.
Del Franco A; Biagioni G; Mazzoni C; Cappelli F
Int J Cardiol; 2024 Jan; 395():131413. PubMed ID: 37802296
[No Abstract] [Full Text] [Related]
16. From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis.
Petkow-Dimitrow P; Rajtar-Salwa R; Holcman K; Kostkiewicz M; Rubiś P
Pol Arch Intern Med; 2020 Feb; 130(2):153-154. PubMed ID: 31933485
[No Abstract] [Full Text] [Related]
17. Prognostic Significance of Occult Transthyretin Cardiac Amyloidosis in Patients With Severe Aortic Stenosis Undergoing Surgical Aortic Valve Replacement: An Unrecognized Disease Modifier.
Koyama J
Circ Cardiovasc Imaging; 2016 Aug; 9(8):. PubMed ID: 27511980
[No Abstract] [Full Text] [Related]
18. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
[TBL] [Abstract][Full Text] [Related]
19. Recognizing Transthyretin Cardiac Amyloidosis in Patients With Aortic Stenosis: Impact on Prognosis.
Sperry BW; Jones BM; Vranian MN; Hanna M; Jaber WA
JACC Cardiovasc Imaging; 2016 Jul; 9(7):904-906. PubMed ID: 27085437
[No Abstract] [Full Text] [Related]
20. Acute cardiac failure secondary to senile systemic amyloidosis.
Bodard Q; Roca F; Dilly B; Laurent D; Chassagne P
Age Ageing; 2016 Nov; 45(6):908-909. PubMed ID: 27103598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
